Brazilian New Pediatric Consensus on Acute Graft-versus-Host Disease (aGvHD): Updates on Prophylaxis, MAGIC Staging, & Therapy Algorithms. Corticosteroids remain 1st line; Ruxolitinib is confirmed for refractory cases.
doi.org/10.46765/267...
#PediatricHemOnc #BMT #GvHD #Hematology #MedSky #JBMTCT
0
0
0
0